Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of PD-L1 expression in metachronous tumor samples and FDG-PET as a predictive biomarker in Ph2 study (FIR) of atezolizumab (MPDL3280A)
    Meeting Abstract

    Chaft, J. E.; Chao, B.; Akerley, W. L.; Gordon, M.; Antonia, S. J.; Callahan, J.; Sandler, A.; Funke, R.; Li, Z.; Fredrickson, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of first-line nivolumab (NIVO; anti-programmed death-1 [PD-1]) and ipilimumab in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Gettinger, S. N.; Goldman, J. W.; Hellmann, M. D.; Chow, L. Q.; Juergens, R.; Borghaei, H.; Brahmer, J. R.; Shen, Y.; Harbison, C.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted ADC, rovalpituzumab tesirine, demonstrates substantial activity in a phase I study in relapsed and refractory SCLC
    Meeting Abstract

    Rudin, C. M.; Pietanza, M. C.; Spigel, D. R.; Bauer, T. M.; Glisson, B.; Robert, F.; Ready, N.; Morgensztern, D.; Kochendoerfer, M. D.; Patel, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Spatiotemporal effects on programmed death ligand 1 (PD-L1) expression and immunophenotype of non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kowanetz, M.; Koeppen, H.; Boe, M.; Chaft, J. E.; Rudin, C. M.; Zou, W.; Nickles, D.; Desai, R.; Nakamura, R.; Sandler, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Targeting gene amplification in squamous cancer
    Meeting Abstract

    Paik, P.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mediastinal tumors including thymic tumors, lymphoma, germ-cell tumors: Biology, diagnosis and treatment
    Meeting Abstract

    Riely, G. J.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • The patient-derived xenograft mouse model dilemma; A new solution for an old problem
    Meeting Abstract

    Schneeberger, V.; Poirier, J.; Rudin, C.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Integrating proteomics and metabolomics characterizes active pathways and potential drug targets in small cell lung cancer
    Meeting Abstract

    Stewart, P. A.; Li, J. N.; Fisher, K. J.; Dhungana, S.; Stewart, D.; Sumner, S.; Gardner, E.; Poirier, J.; Rudin, C. M.; Welsh, E. A.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save